EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹132 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹310 Cr |
| Mar2021 | ₹222 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -6.26 | |
| Mar2024 | ₹132 Cr | -67.20 | |
| Mar2023 | ₹404 Cr | 30.25 | |
| Mar2022 | ₹310 Cr | 39.81 | |
| Mar2021 | ₹222 Cr | - | |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹30,350.2 Cr | 3.1% | 5.3% | 55% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.1% |
5.3% |
55% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses